Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome

NCT03540810 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER_GOV

Sponsor class

Conditions

Primary Antiphospholipid Syndrome

Interventions

DRUG: Hydroxychloroquine
DRUG: Placebo

Sponsor

University Hospital, Angers